Back to Search
MICHAEL RYTTING, M.D.
M.D.
Pediatric Hematology & Oncology Physician
NPI: 1548366628Individual
Specialties, Licenses & Credentials
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
J5465(TX)
Research & Publications (12)
Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activity.
PMID 19605811·Am J Clin Pathol·2009
8-other
Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy.
PMID 15370215·Leuk Lymphoma·2004
5-case
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
PMID 19652076·J Clin Oncol·2009
3-trial
Unusual expression of CD94 on CD8+ TCR-alpha beta T cells in infectious mononucleosis.
PMID 17240309·Ann Diagn Pathol·2007
5-case
Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia.
PMID 16882711·Blood·2006
3-trial
Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions.
PMID 16639734·Cancer·2006
4-observational
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
PMID 16622268·J Clin Oncol·2006
3-trial
Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia.
PMID 15750451·J Pediatr Hematol Oncol·2005
5-case
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
PMID 15496649·J Clin Pharmacol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4815 Alameda Ave
El Paso, TX 79905 - Phone
- (915) 215-5700
Quick Facts
- NPI
- 1548366628
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 2
- Publications
- 12
Are you this provider?
Claim Your Profile